Product Overview
Bevacizumab Biosimilar 400mg Injection is a targeted anti-cancer therapy widely used in oncology treatment protocols. Manufactured and exported by Cordium Pharmaceuticals Pvt Ltd, this biosimilar offers high quality, cost-effective treatment solutions for international healthcare providers, hospitals, and distributors.
Cordium Pharmaceuticals is recognized as a leading pharmaceutical exporter in India, ensuring reliable global delivery with strict quality compliance and fast shipping.
Key Features
- Generic Name: Bevacizumab Biosimilar
- Strength: 400 mg Injection
- Dosage Form: Injectable (IV Infusion)
- Therapeutic Class: Anti-VEGF Monoclonal Antibody
- Packaging: Export-grade secure packaging
- Quality Compliance: WHO-GMP standards
Medical Uses
Bevacizumab is commonly prescribed for the treatment of various cancers, including:
- Colorectal Cancer
- Non-Small Cell Lung Cancer
- Kidney Cancer
- Cervical Cancer
- Ovarian Cancer
This biosimilar works by inhibiting angiogenesis (blood vessel formation), helping to slow or stop tumor growth.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
- Trusted global oncology medicine exporter from India
- Competitive pricing for bulk and wholesale buyers
- Fast and secure international shipping
- Reliable supply chain for hospitals and distributors
- Regulatory-compliant export documentation
Global Export Markets
We supply Bevacizumab Biosimilar 400mg Injection with fast shipping to:
- USA: Washington, New York, San Francisco
- Philippines
- United Kingdom: London, Birmingham, Manchester
- South Africa
- UAE: Dubai, Abu Dhabi, Oman, Qatar
- Canada
- Singapore
Packaging & Shipping
- Temperature-controlled logistics available
- Safe, tamper-proof export packaging
- Express international courier options
- Real-time shipment tracking
Bulk Orders & Enquiries
For bulk orders, hospital supply, or distributor partnerships, contact Cordium Pharmaceuticals Pvt Ltd today for competitive quotes and fast dispatch.
